Jennifer C King, PhD, Director of Science and Research at the Lung Cancer Alliance, Washington, DC, talks to us about unmet needs in non-small cell lung cancer and the role Lung Cancer Alliance plays in supporting patients and research.
1. Could you tell us a little about the services provided by the Lung Cancer Alliance? (0:11)
2. Could you give us a brief overview of the areas of research supported by the Lung Cancer Alliance? (1:02)
3. What do you consider the most important unmet needs in the treatment of non-small cell lung cancer (NSCLC)? (1:40)
4. What research advances in NSCLC therapy have excited you most in the last year? (2:45)
5. What do you expect to be the highlights of this year’s ASCO conference? (4:00)
Speaker disclosures: Jennifer C King has nothing to disclose in relation to this video interview.
Filmed at the American Society of Clinical Oncology (ASCO) Annual Meeting 2018, Chicago, IL, US, June 1–5 2018